Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Effects of TxA2 antagonists on IL-8-induced bronchial hyperresponsiveness

Jan. 7, 1998

Antitussive properties of Chinoin xanthine explored

Jan. 7, 1998

FDA clears new Allegra product; Seldane to be withdrawn

Jan. 7, 1998

New class of orally active bradykinin B2 antagonists presented by Fujisawa

Jan. 2, 1998

Commencement of phase II trials of LiquiVent for adult ARDS

Dec. 31, 1997

IL-5 receptor ligands reported by Glaxo Wellcome

Dec. 31, 1997

New treatment approach for nasal congestion

Dec. 30, 1997

TOBI approved by FDA for management of CF patients

Dec. 29, 1997

New antiallergic agents from Dainippon Ink & Chemicals

Dec. 29, 1997

Teijin starts clinical trials of in-licensed antiasthmatic drug

Dec. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...